Navigation Links
Myoclonus Global Clinical Trials Review, H2, 2014
Date:8/5/2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Myoclonus Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256142/Myoclonus-Global-Clinical-Trials-Review-H2-2014.html

Myoclonus Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Myoclonus 5

Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Myoclonus to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Myoclonus to Central Nervous System Clinical Trials 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Myoclonus 22

Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Myoclonus Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Taro Pharmaceutical Industries Ltd. 28
Clinical Trial Overview of Taro Pharmaceutical Industries Ltd. 28
Clinical Trial Overview of Top Institutes / Government 29
National Pediatric Myoclonus Center 29
Clinical Trial Overview of National Pediatric Myoclonus Center 29
Nanjing Medical University 30
Clinical Trial Overview of Nanjing Medical University 30
First Affiliated Hospital of Henan College 31
Clinical Trial Overview of First Affiliated Hospital of Henan College 31
Foundation IRCCS Neurological Institute Carlo Besta 32
Clinical Trial Overview of Foundation IRCCS Neurological Institute Carlo Besta 32
Hospital Sant Joan de Deu Barcelona 33
Clinical Trial Overview of Hospital Sant Joan de Deu Barcelona 33

National Institute of Neurological Disorders and Stroke 34
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 34
Assistance Publique - Hopitaux de Paris 35
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 35
Academic Medical Center 36
Clinical Trial Overview of Academic Medical Center 36
Mashhad University of Medical Sciences 37
Clinical Trial Overview of Mashhad University of Medical Sciences 37
Institut Curie 38
Clinical Trial Overview of Institut Curie 38
Five Key Clinical Profiles 39
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables

Myoclonus Therapeutics, Global, Clinical Trials by Region, 2014* 6
Myoclonus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Myoclonus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Myoclonus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Myoclonus Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Myoclonus Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Myoclonus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Myoclonus to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Myoclonus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Myoclonus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Myoclonus to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Myoclonus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Myoclonus Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Myoclonus Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Myoclonus Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Myoclonus Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Myoclonus Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Myoclonus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Myoclonus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24

Myoclonus Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Myoclonus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Myoclonus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Taro Pharmaceutical Industries Ltd., 2014* 28
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by National Pediatric Myoclonus Center, 2014* 29
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2014* 30
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by First Affiliated Hospital of Henan College, 2014* 31
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Foundation IRCCS Neurological Institute Carlo Besta, 2014* 32
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Sant Joan de Deu Barcelona, 2014* 33
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 34
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 35
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 36
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014* 37
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2014* 38

List of Figures

Myoclonus Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Myoclonus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Myoclonus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Myoclonus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Myoclonus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Myoclonus Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Myoclonus to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Myoclonus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Myoclonus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Myoclonus to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Myoclonus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Myoclonus Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Myoclonus Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Myoclonus Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Myoclonus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Myoclonus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Myoclonus Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Myoclonus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 70

To order this report: Myoclonus Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256142/Myoclonus-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Neuralgia Global Clinical Trials Review, H2, 2014
2. Multiple Sclerosis Global Clinical Trials Review, H2, 2014
3. Muscle Spasticity Global Clinical Trials Review, H2, 2014
4. Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014
5. Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014
6. Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014
7. Mania Global Clinical Trials Review, H2, 2014
8. Global Market for DNA Vaccines to Reach $2.7 Billion in 2019; Clinical Vaccines Segment Surging at 81.2% CAGR
9. Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018
10. Ability Dynamics Announces Global Growth
11. Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & Whole Slide Image Storage - Global Forecasts & Trends to 2018. In New Research Report Available at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... The OSHA Training Center at ... Center headquartered in Northern California, has issued an important reminder to employers to ... Employers with workers exposed to high temperatures should establish a complete heat ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):